Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The amyloid β protein precursor (AβPP) is sequentially processed by β- and γ-secretases to generate the Aβ peptide. The biochemical path leading to Aβ formation has been extensively studied since extracellular aggregates of amyloidogenic forms of Aβ peptide (Aβ42) are considered the culprit of Alzheimer's disease. Aside from its pathological relevance, the biological role of AβPP proteolysis is unknown. Although never previously described, cleavage of AβPP by γ-secretase should release, together with Aβ, a COOH-terminal AβPP Intracellular Domain, herein termed AID. We have now identified AID-like peptides in brain tissue of normal control and patients with sporadic Alzheimer's disease and demonstrate that AID acts as a positive regulator of apoptosis. Thus, overproduction of AID may add to toxic effect of Aβ42 aggregates and further accelerate neurodegeneration.

Original publication




Journal article


Journal of Alzheimer's Disease

Publication Date





289 - 301